<DOC>
	<DOCNO>NCT00327834</DOCNO>
	<brief_summary>The specific aim study assess efficacy safety atomoxetine compare placebo outpatient binge eat disorder .</brief_summary>
	<brief_title>Atomoxetine Treatment Binge Eating Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Feeding Eating Disorders</mesh_term>
	<mesh_term>Binge-Eating Disorder</mesh_term>
	<mesh_term>Bulimia</mesh_term>
	<mesh_term>Atomoxetine Hydrochloride</mesh_term>
	<criteria>Subjects meet DSMIV criterion diagnosis bingeeating disorder least last 6 month In addition , subject report least 3 binge eat episode per week last 6 month prior randomization Have concurrent symptom bulimia nervosa anorexia nervosa Women pregnant , lactating , child bear potential use adequate contraceptive measure Patients display clinically significant suicidality homicidality</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2011</verification_date>
</DOC>